Revenue $1.88B, up 8.1% on a year earlier. Agilent CrossLab Group revenue $786.00M, up 5.6%. Diluted EPS $1.28 against $1.18.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $1.88B | $1.83B | $1.74B | +8.1% |
| Operating income | $444.00M | $399.00M | $360.00M | +23.3% |
| Net income | $362.00M | $339.00M | $336.00M | +7.7% |
| Diluted EPS | $1.28 | $1.20 | $1.18 | |
| Operating cash flow | $519.00M | $277.00M | $362.00M | +43.4% |
| Capital expenditures | -$80.00M | -$76.00M | -$103.00M | |
| Free cash flow | $439.00M | $201.00M | $259.00M | +69.5% |
| Dividend per share | $0.26 | $0.26 | $0.25 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Agilent CrossLab Group revenue | $786.00M | $744.00M | +5.6% |
| Core revenue growth | 7.3% | 6.1% |
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| Q3 FY26 | Revenue | $1.83B to $1.85B | $1.88B | above |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Agilent Technologies (A) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/A/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
